Get the app
NSEHealthcare

Aster DM Healthcare Limited (ASTERDM)

NSE · Healthcare · Medical Care Facilities

₹760.65+2.62%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
₹1,311 cr
Revenue YoY
+21.6%
Net profit
₹16 cr
Profit YoY
-81.2%
EPS
₹1.14
EPS estimate
₹2.30
Net margin
1.2%

EPS came in at 1.14 against a street estimate of 2.30 — a miss of 50.4%.

Key statistics

Market cap
₹66,513 cr
P/E
123.5
Forward P/E
11.4
P/B
14.54
Book value
₹88.80
EPS (TTM)
₹6.18
52-week high
₹891.30
52-week low
₹516.83
50-day MA
₹800.41
200-day MA
₹701.71
Beta
-0.08

Analyst view

with an average price target of ₹931.55.

From the latest earnings call · 2026-08-05

CONFIDENT Merged entity Aster DM Quality Care delivered strong Q1 FY27 with 20% revenue growth to ₹2,597cr and 30% EBITDA growth to ₹576cr (22.2% margin). 39 hospitals, 7,400 doctors, 2M quarterly patients. Synergies not yet realized; 10-15% EBITDA accretion targeted in coming years. Targeting 24-25% EBITDA margins by FY28-29. Q1 FY27 Kerala showed strong recovery with 25% growth (20% excluding Kasaragod), volume-driven. Karnataka recovered from single-digit growth to 16% with 18 doctors added in Bangalore in Q1. All 3 Hyderabad hospitals (CMI, Whitefield, RV) clocked highest revenue from inception in June. Analysts pressed on independent performance sustainability (Karnataka, Kerala), synergy timing, and organizational structure (3 India CEOs, maturity-based reporting). Management clarified: synergies have not started (Q1 performance independent), focus units recovering via clinical pro…

Full summary in the app.

Shareholding

Promoters
64.26%
Institutions
20.21%

Recent filings & reports

DocumentDate
Annual report FY2026
ASTER DM QUALITY CARE LIMITED - FY 2025-26 SUMMARY HEADLINE NUMBERS • Document Type: Integrated Annual Report submission for FY 2025-26 (financial y
2026-09-05
Q1 FY27 earnings call
ASTER DM QUALITY CARE LIMITED – Q1 FY27 SUMMARY HEADLINE NUMBERS • Revenue from Operations: INR 2,597 crores (combined proforma basis), up 20% year-
2026-08-12
Quarterly results · Q1 FY27
ASTER DM QUALITY CARE LIMITED - Q1 FY27 RESULTS SUMMARY HEADLINE NUMBERS • Combined Revenue (Proforma): INR 2,597 Cr, up 20% YoY • Operating EBITDA
2026-08-05
Investor presentation · Q1 FY27
ASTER DM QUALITY CARE LIMITED - Q1 FY27 SUMMARY HEADLINE NUMBERS • Revenue from Operations: INR 2,597 Cr (proforma combined entity), up 20% YoY; Ast
2026-08-05
Investor presentation · Q4 FY26
INVESTOR SUMMARY: ASTER DM HEALTHCARE LIMITED HEADLINE NUMBERS • Revenue FY26: INR 4,643 Cr (26% CAGR over 3 years) • Operating EBITDA FY26: INR 947
2026-06-03
Q4 FY26 earnings call
ASTER DM HEALTHCARE LIMITED – Q4 FY26 SUMMARY HEADLINE NUMBERS • Q4 FY26 Combined Proforma Revenue (Aster + QCIL): INR 2,361 crores, up 18% year-on-
2026-05-08
Quarterly results · Q4 FY26
ASTER DM HEALTHCARE LIMITED – FINANCIAL SUMMARY Q4 & FY 2025-26 Results (Year Ended March 31, 2026) --- HEADLINE NUMBERS • FY 2025-26 Revenue from
2026-04-30
Investor presentation2026-04-30

Readable in the app.

Corporate actions

ActionDetailDate
Dividend₹3 / share
ex-date Apr 2, 2026 · record Apr 3, 2026
2026-04-02
Dividend₹1 / share
ex-date Aug 28, 2025
2025-08-28

Deals & corporate news

AnnouncementDate
Capacity expansion announced at material subsidiary facility
Aster DM Quality Care Limited announced a capacity expansion at its material subsidiary KIMS Health Care Management Limited's Trivandrum hospital. The board approved construction of a new bl
2026-08-31
Subsidiary acquires equity shares in STS Holdings Limited
Aster DM Quality Care Limited's Mauritian subsidiary acquired a 14.21% stake in STS Holdings Limited, a Bangladesh-based healthcare services company, for USD 44.1 million (approximately BDT
2026-08-28
Trading approval received for equity shares allotted under scheme of amalgamation
Aster DM Quality Care Limited (formerly Aster DM Healthcare Limited) has received trading approval from both NSE and BSE for 35.36 crore newly allotted equity shares. These shares were issue
2026-08-14
Acquisition of equity shares in United CIIGMA Institute of Medical Sciences
Aster DM Healthcare has acquired equity shares in United CIIGMA Institute of Medical Sciences, which is already a subsidiary of the company. This means Aster increased its ownership stake in
2026-08-05
Allotment of equity shares to QCIL shareholders pursuant to amalgamation scheme
Aster DM Healthcare Limited has completed the allotment of equity shares to shareholders of QCIL (the transferor company) as part of an approved scheme of amalgamation. This means QCIL has b
2026-07-13

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Aster DM Healthcare Limited — free to start.

Google PlayApp Store

Other Healthcare companies

Data updated 2026-09-18.